<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04958174</url>
  </required_header>
  <id_info>
    <org_study_id>WP-2021-02</org_study_id>
    <nct_id>NCT04958174</nct_id>
  </id_info>
  <brief_title>A Smartphone Application for Screening of Developmental Disorders in Children</brief_title>
  <official_title>A Smartphone Application for Screening of Developmental Disorders in Children: a Prospective Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weprom</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kelindi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Weprom</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The detection of developmental disorders in the child is often late because the parents do&#xD;
      not have the information necessary to consult at the first clinical signs. For example, the&#xD;
      diagnosis of autism spectrum disorders is made at the age of 5, so earlier diagnoses are&#xD;
      possible earlier or even in the 1st year with appropriate questionnaires.&#xD;
&#xD;
      An application (Malo) has been developed to allow through regular questionnaires from 1 month&#xD;
      to 3 years old to assess the child's development by his parents in the form of a digital&#xD;
      health record assessing several areas at regular intervals (monthly the 1st year then every 3&#xD;
      to 12 months): sensory, psychomotor development, sleep, height and weight, cognitive and&#xD;
      addictions (especially to screens). The questions will be adapted to the age of the child. An&#xD;
      alert suggesting to consult the general practitioner or the pediatrician will be generated&#xD;
      according to an algorithm validated by a committee of experts.&#xD;
&#xD;
      Based on a study model on health data already carried out as part of the triage application&#xD;
      for patients suspected of COVID 19 coronavirus disease.fr with 14 million users in 6 months&#xD;
      having improved the relevance of calls to the 15 (8 times fewer unnecessary calls) and&#xD;
      general practitioners.&#xD;
&#xD;
      This study will assess parental interest in this application.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 15, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>usefulness</measure>
    <time_frame>6 months</time_frame>
    <description>number of users who find the application useful</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alert</measure>
    <time_frame>6 months</time_frame>
    <description>Description of alerts triggered by algorithms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consultation</measure>
    <time_frame>6 months</time_frame>
    <description>Number of relevant consultations (or teleconsultations) after an alert</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Development, Child</condition>
  <arm_group>
    <arm_group_label>Users</arm_group_label>
    <description>Users of the web-application</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>web-application</intervention_name>
    <description>web application for monitoring children's development</description>
    <arm_group_label>Users</arm_group_label>
    <other_name>MALO</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The application will be made available to Sarthois after a launch campaign by local media&#xD;
        for parents with children aged 1 month to 3 years. The population will include the first&#xD;
        180 users of the application who did not object to the use of their data for this&#xD;
        assessment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Parent of a child or more under 3 years of age (1 month to 3 years)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Parent of a child who has already been diagnosed with a developmental disorder, known&#xD;
             physical or mental disability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>3 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Fabrice DENIS, Pr</last_name>
    <role>Study Director</role>
    <affiliation>Weprom</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magali BALAVOINE</last_name>
    <phone>241682940</phone>
    <phone_ext>0033</phone_ext>
    <email>m.balavoine@ilcgroupe.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>ILC</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Fabrice DENIS, Pr</last_name>
      <email>f.denis@ilcgroupe.fr</email>
    </contact>
    <investigator>
      <last_name>Fabrice DENIS, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Developmental Disabilities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

